Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ABS Vaccines
Rockville, Maryland, United States
- Ownership
- Private
- Development stage
- Other
01
Overview
ABS Vaccines is a biotechnology company focused on the development of novel vaccines targeting bacterial infections, particularly those caused by Staphylococcus aureus and Streptococcus pneumoniae. The company utilizes recombinant protein technology to create multivalent vaccine candidates designed to provide broad protection against diverse clinical isolates. Their lead research efforts involve identifying conserved surface proteins that can elicit robust immune responses. ABS Vaccines aims to address the growing global threat of antibiotic-resistant bacteria through preventative immunization strategies.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccineRecombinant protein
- Industry
- Biotech
Beyond the preview
Go deeper on ABS Vaccines.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ABS Vaccines.